2018
DOI: 10.1016/j.ejpb.2018.05.020
|View full text |Cite
|
Sign up to set email alerts
|

Looking inside the ‘black box’: Freezing engineering to ensure the quality of freeze-dried biopharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
35
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 40 publications
(36 citation statements)
references
References 14 publications
1
35
0
Order By: Relevance
“…
Fig. 28 Resistance to water vapor as a function of product depth in the case of different freezing protocols for mannitol solutions: ( ) VISF [23] , ( ) suspended-vial freezing [22] , ( ) conventional freezing [21] , and in the case of water-TMDD particle-based products atomized at ( ) 24 kHz and ( ) 48 kHz [1] .
…”
Section: Videomentioning
confidence: 99%
See 2 more Smart Citations
“…
Fig. 28 Resistance to water vapor as a function of product depth in the case of different freezing protocols for mannitol solutions: ( ) VISF [23] , ( ) suspended-vial freezing [22] , ( ) conventional freezing [21] , and in the case of water-TMDD particle-based products atomized at ( ) 24 kHz and ( ) 48 kHz [1] .
…”
Section: Videomentioning
confidence: 99%
“…28 show a comparison of the resistance to vapor flow for particle-based material and bulk products. The mannitol-based bulk products were produced using the conventional freezing [21], using suspended-vial freezing [22] and vacuum-induced surface freezing (VISF) [23], [24]. For the particle-based material, the frozen microparticles consisted of a water mixture 35% w/w of TMDD atomized at 48 kHz and 24 kHz [1].
Fig.
…”
Section: Videomentioning
confidence: 99%
See 1 more Smart Citation
“…The nucleation temperature determines the morphology of the final product, with a high nucleation temperature resulting in larger ice crystals (Searles et al, 2001). In turn, the ice crystal size corresponds to the pore size of the dried product, provided that no collapse occurs, and has therefore an impact on process efficiency (Capozzi and Pisano, 2018;Hottot et al, 2007;Kasper and Friess, 2011;Pikal et al, 2002). For instance, a large pore size speeds up the removal of water by sublimation, reducing the primary drying time, but results in a slow desorption rate during secondary drying (Oddone et al, 2016;Oddone et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…4,5 In general, the freezing process should be carefully controlled to ensure the quality of freeze-dried biopharmaceuticals. 6 By contrast, during drying, the main stress that could cause the protein denaturation is the removal of the shell of water surrounding the protein surface. 7 These side effects can result in protein unfolding and aggregation, which in any case lead to loss of the pharmaceutical activity.…”
Section: Introductionmentioning
confidence: 99%